In-vitro for Q-RT-PCR Clinical Evaluation of Oscardia Ledovir Spray Effectiveness on SARS-CoV-2 and Its Effective Variants
Open Access
- 29 November 2022
- journal article
- Published by Xia & He Publishing in Exploratory Research and Hypothesis in Medicine
- Vol. 000 (000) , 000
Abstract
The real target planned is the prevention of COVID-19 using natural treatment tools, other than medical drugs, together with the use of vaccines. Similar to various viruses that lead to upper respiratory diseases, SARS-CoV-2 most frequently enters the body through the nasal cavity and oral cavity. It has been stated that the Oscardia Ledovir Spray can form a mechanical barrier in the mucosa of the nasal and oral cavities, which are the points of entry of the SARS-CoV-2 virus in the body, preventing the bonding of the virus to the receptors, and inhibiting any virus it encounters through direct contact.Keywords
This publication has 29 references indexed in Scilit:
- Comparison of COVID‐19 laboratory diagnosis by commercial kits: Effectivity of RT‐PCR to the RT‐LAMPJournal of Medical Virology, 2022
- The evaluation of potential global impact of the N501Y mutation in SARS‐COV‐2 positive patientsJournal of Medical Virology, 2021
- Effect of different storage conditions on COVID‐19 RT‐PCR resultsJournal of Medical Virology, 2021
- Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized controlled trialAmerican Journal of Otolaryngology, 2021
- The Association of “Loss of Smell” to COVID-19: A Systematic Review and Meta-AnalysisThe American Journal of the Medical Sciences, 2021
- Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19European Journal of Clinical Pharmacology, 2020
- COVID-19 and anosmia: A review based on up-to-date knowledgeAmerican Journal of Otolaryngology, 2020
- The epidemiology, diagnosis and treatment of COVID-19International Journal of Antimicrobial Agents, 2020
- Dexpanthenol: An Overview of its Contribution to Symptom Relief in Acute Rhinitis Treated with Decongestant Nasal SpraysAdvances in Therapy, 2017
- Cholinesterase inhibitors for Alzheimer's diseaseCochrane Database of Systematic Reviews, 2006